Patient recruitment strategies for success

In the face of pressure from all quarters, pharmaceutical companies are actively exploring faster, cheaper, offshore drug development options. Companies often experience significant delays in completing clinical trials; in many cases up to one-third of originally planned timelines. Those businesses that adopt a strategic approach to offshoring clinical trials can expect to significantly reduce these delays and also the costs of clinical research.

[DOWNLOAD PDF]

For more information, please contact the authors:
Wynn Bailey
Carol Cruickshank
Nikhil Sharma

August 2007